Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07442357
NA

The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial

Sponsor: Copenhagen University Hospital, Rigshospitalet

View on ClinicalTrials.gov

Summary

The study is a prospective, crossover, cluster randomized trial in patients undergoing transcatheter aortic valve implantation (TAVI). The study tests whether cephalosporin plus beta-lactam antibiotic with spectrum for Enterococcus faecalis as per procedural prophylaxis is superior to cephalosporin alone in reducing the composite outcome of bacteremia or death at 6 months post-TAVI.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1986

Start Date

2026-10-01

Completion Date

2030-03-31

Last Updated

2026-10-05

Healthy Volunteers

No

Interventions

DRUG

Beta-lactam antibiotic with spectrum for Enterococcus faecalis

Beta-lactam antibiotic with spectrum for Enterococcus faecalis (e.g. ampicillin 2g) add-on in combination with cephalosporin as per-procedural prophylaxis in TAVI

DRUG

Cephalosporin

Cephalosporin treatment

Locations (5)

Aalborg University Hospital

Aalborg, Denmark

Aarhus University Hospital

Aarhus, Denmark

Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

Odense University Hospital

Odense, Denmark

Skåne University Hospital Lund

Lund, Sweden